Citadel Advisors’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159K Sell
42,700
-26,500
-38% -$183K ﹤0.01% 11635
2025
Q4
$566K Buy
+69,200
New +$512K ﹤0.01% 8723
2025
Q2
Sell
-1,400
Closed -$9.86K 14054
2025
Q1
$9.86K Buy
+1,400
New +$8.7K ﹤0.01% 13572
2024
Q3
Sell
-4,200
Closed -$21.5K 14882
2024
Q2
$21.5K Sell
4,200
-25,600
-86% -$152K ﹤0.01% 12567
2024
Q1
$158K Buy
+29,800
New +$213K ﹤0.01% 10683
2023
Q4
Sell
-34,000
Closed -$257K 14879
2023
Q3
$257K Sell
34,000
-8,200
-19% -$75K ﹤0.01% 9450
2023
Q2
$408K Buy
42,200
+16,700
+65% +$102K ﹤0.01% 8374
2023
Q1
$96.3K Buy
25,500
+22,300
+697% +$124K ﹤0.01% 11323
2022
Q4
$20.7K Buy
+3,200
New +$26.4K ﹤0.01% 13120
2022
Q2
Sell
-11,100
Closed -$129K 13679
2022
Q1
$129K Buy
+11,100
New +$124K ﹤0.01% 12020

Other funds holding LFCR